2m 2m 2m 2m 2m 2m 2m
INMED PHARMA (INM)
NASDAQ
$1.26-$0.04 (-2.71%)
Price as of Sep 11, 2026 6:24 PM EDT- $6.9MMarket Cap
- -39.72%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INMED PHARMA (INM)
$1.26-$0.04 (-2.71%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 4.9M +7.50% | 4.6M +11.18% | 4.1M +279.61% | |
Cost of Revenue | N/A N/A | 3.2M -7.46% | 3.5M +44.28% | 2.4M +343.97% | |
Gross Profit | 0 -100.00% | 1.7M +55.02% | 1.1M -21.53% | 1.4M +158.13% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -3.0M +6.12% | -2.9M -24.20% | -3.8M +0.88% | -3.7M -48.75% | |
Depreciation and Amortization Expense | 205,271 -3.56% | 212,839 -3.08% | 219,600 +8.58% | 202,249 +8.94% | |
Total Operating Expenses | 11.6M +20.25% | 9.7M +3.83% | 9.3M -4.95% | 9.8M -45.07% | |
Operating Profit | -11.4M +39.34% | -8.2M +6.44% | -7.7M -3.35% | -7.9M -57.34% | |
Interest Income | 244,971 +57.15% | 155,882 -70.47% | 527,901 +7.20% | 492,440 +412.48% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 244,971 +57.15% | 155,882 -70.47% | 527,901 +7.20% | 492,440 +412.48% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 527,901 +22.44% | 431,165 N/A | |
Income before Taxes | -11.4M +39.34% | -8.2M +6.44% | -7.7M -3.35% | -7.9M -57.34% | |
Income Taxes | N/A N/A | N/A N/A | 7,100 -45.80% | 13,100 N/A | |
Extraordinary Items | 189,225 N/A | N/A N/A | N/A N/A | 2.0M N/A | |
Net Income | -13.0M +59.18% | -8.2M +6.34% | -7.7M -3.42% | -7.9M -57.27% | |
Net Income from Continuing Operations Applicable to Common | -11.4M +39.34% | -8.2M +6.44% | -7.7M -3.35% | -7.9M -57.34% | |
Basic EPS and Net Income | -3.12 -62.68% | -8.36 +727.72% | -1.01 -68.92% | -3.25 -90.20% | |
Diluted EPS and Net Income | -3.12 -62.68% | -8.36 +727.72% | -1.01 -68.92% | -3.25 -90.20% | |
Basic Weighted Average Shares | 4.2M +326.60% | 975,985 -87.19% | 7.6M +211.26% | 2.4M +336.58% | |
Diluted Weighted Average Shares | 4.2M +326.60% | 975,985 -87.19% | 7.6M +211.26% | 2.4M +336.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.2M -80.19% | 11.1M +68.54% | 6.6M -26.27% | 8.9M +44.29% | |
Short-Term Investments | 39,670 -8.56% | 43,384 +0.74% | 43,064 -3.06% | 44,422 -0.85% | |
Cash and Cash Equivalents and Short-Term Investments | 2.2M -79.91% | 11.1M +68.10% | 6.6M -26.15% | 9.0M +43.96% | |
Total Current Assets | 2.7M -79.20% | 12.9M +48.08% | 8.7M -23.32% | 11.3M +18.07% | |
Accumulated Depreciation | 373,290 -72.11% | 1.3M -1.25% | 1.4M +46.47% | 925,321 +79.16% | |
Property and Plant and Equipment and Net | 221,037 -77.72% | 992,199 -20.62% | 1.2M N/A | N/A N/A | |
Total Long-Term Assets | 132,324 +32.32% | 100,000 0.00% | 100,000 -4.68% | 104,908 -40.61% | |
Total Assets | 3.0M -80.55% | 15.6M +31.78% | 11.8M -16.19% | 14.1M +10.31% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.0M +6.27% | 1.8M -6.70% | 2.0M -1.44% | 2.0M -39.73% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | N/A N/A | 305,755 -52.59% | 644,865 +3,931.92% | 15,994 -95.89% | |
Total Liabilities | 2.0M -8.88% | 2.1M -18.00% | 2.6M +29.76% | 2.0M -45.63% | |
Retained Earnings | -130.2M +11.08% | -117.2M +7.48% | -109.1M +7.57% | -101.4M +8.50% | |
Total Stockholders Equity | 1.1M -92.00% | 13.4M +45.93% | 9.2M -23.85% | 12.1M +33.17% | |
Total Shares Outstanding | 5.3M +166.68% | 2.0M -77.55% | 8.9M +167.98% | 3.3M +411.50% | |
Cash Flow | |||||
Cash from Operating Activities | -8.6M +11.29% | -7.8M +11.18% | -7.0M -4.08% | -7.3M -53.26% | |
Capital Expenditures | N/A N/A | N/A N/A | 9,293 -94.19% | 160,014 +309.16% | |
Cash from Investing Activities | N/A N/A | N/A N/A | -9,293 -98.60% | -661,804 -1.66% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 94,496 -99.23% | 12.3M +163.66% | 4.7M -56.42% | 10.7M -29.13% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 34.53% +44.20% | 23.94% -42.16% | 41.40% -17.03% | |
Operating Margin | N/A N/A | -165.14% -0.99% | -166.79% -13.07% | -191.86% -88.76% | |
Return on Assets | -139.63% +134.39% | -59.57% +0.62% | -59.20% +0.17% | -59.10% -64.14% | |
Return on Equity | -179.09% +148.38% | -72.10% +0.02% | -72.08% -4.00% | -75.09% -66.78% | |
Revenue Growth | N/A N/A | 7.50% -32.87% | 11.18% -96.00% | 279.61% N/A | |
Current Ratio | 1.37 -80.42% | 6.99 +58.70% | 4.41 -22.20% | 5.66 +95.90% | |
Cash Ratio | 1.12 -81.36% | 6.02 +80.63% | 3.33 -25.19% | 4.45 +139.41% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow